Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|93|3|275-282

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.93, Iss.3, 2013-03, pp. : 275-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of OATP1B1, MDR1 and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 428-428

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β‐catenin

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E32-E42

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 5, 2015-05 ,pp. : 534-542

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ethnic Variability in the Plasma Exposures of OATP1B1 Substrates Such as HMG‐CoA Reductase Inhibitors: A Kinetic Consideration of Its Mechanism

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 37-51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biliary and renal excretions of ginsenosides

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 4, 2015-02 ,pp. : 1059-1073

John Wiley & Sons Inc

Access to resources Recommend Favorite